Nonpartisan civic infrastructure
AllCiv·Legis1
·

S. 4351

BillFederalSenateIntroduced
To amend the Federal Food, Drug, and Cosmetic Act to clarify the conditions under which the Secretary of Health and Human Services can approve generic drug applications with labeling temporarily different than the brand name drug, and for other purposes.
About This Bill
Introduced
Introduced
June 6, 2022
Cosponsors (3)
3D 0R
View PDF ↗
SummaryFull TextCommentsAnnotations

Annotations on Text

0 annotations · Highlight text on the Summary or Full Text tab to add one
No annotations yet. Highlight a passage of the text to add one.

Take Action

Your position
Add a comment
to comment on this bill.
Annotate the text
Highlight any passage on the Summary or Full Text tab to attach a note. Annotations appear on the Annotations tab.